ProCE Banner Activity

New and Emerging Agents for Schizophrenia

Slideset Download

Slides from the schizophrenia presentation at the 8th Annual Psychopharmacology Update 2022

Released: November 28, 2022

Expiration: November 27, 2023

No longer available for credit.

Share

Faculty

Jonathan M. Meyer

Jonathan M. Meyer, MD

Voluntary Clinical Professor of Psychiatry
University of California, San Diego
Distinguished Life Fellow
American Psychiatric Association
San Diego, California

Supporters

Supported by educational grants from

Independent Educational Activity

Faculty Disclosure

Primary Author

Jonathan M. Meyer, MD

Voluntary Clinical Professor of Psychiatry
University of California, San Diego
Distinguished Life Fellow
American Psychiatric Association
San Diego, California

Jonathan M. Meyer, MD: consultant/advisor/speaker: Alkermes, Axsome, Cerevel, Intra-Cellular Therapies, Karuna, Neurocrine, Noven, Relmada, Teva.